136 related articles for article (PubMed ID: 8752671)
1. c-myb proto-oncogene is expressed by quiescent scleroderma fibroblasts and, unlike B-myb gene, does not correlate with proliferation.
Piccinini G; Luchetti MM; Caniglia ML; Carossino AM; Montroni M; Introna M; Gabrielli A
J Invest Dermatol; 1996 Jun; 106(6):1281-6. PubMed ID: 8752671
[TBL] [Abstract][Full Text] [Related]
2. C-myb, but not B-myb, upregulates type I collagen gene expression in human fibroblasts.
Piccinini G; Golay J; Flora A; Songia S; Luchetti M; Gabrielli A; Introna M
J Invest Dermatol; 1999 Feb; 112(2):191-6. PubMed ID: 9989795
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts.
Trojanowska M; Wu LT; LeRoy EC
Oncogene; 1988 Oct; 3(4):477-81. PubMed ID: 3078955
[TBL] [Abstract][Full Text] [Related]
4. B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines.
Arsura M; Introna M; Passerini F; Mantovani A; Golay J
Blood; 1992 May; 79(10):2708-16. PubMed ID: 1586718
[TBL] [Abstract][Full Text] [Related]
5. Regulation of proliferation and cytokine expression of bone marrow fibroblasts: role of c-myb.
Szczylik C; Skorski T; Ku DH; Nicolaides NC; Wen SC; Rudnicka L; Bonati A; Malaguarnera L; Calabretta B
J Exp Med; 1993 Sep; 178(3):997-1005. PubMed ID: 7688794
[TBL] [Abstract][Full Text] [Related]
6. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression.
Sala A; Calabretta B
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10415-9. PubMed ID: 1438227
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-myb and B-myb oncogenes on myelofibrotic marrow fibroblasts.
Scortechini AR; Rupoli S; Piccinini G; Luchetti MM; Cantori I; Gabrielli A; Leoni P
Leuk Lymphoma; 1999 Apr; 33(3-4):295-304. PubMed ID: 10221509
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-myc, c-myb, and c-sis in fibroblasts from affected and unaffected skin of patients with systemic sclerosis.
Feghali CA; Boulware DW; Ferriss JA; Levy LS
Autoimmunity; 1993; 16(3):167-71. PubMed ID: 8003611
[TBL] [Abstract][Full Text] [Related]
9. B-Myb acts as a repressor of human COL1A1 collagen gene expression by interacting with Sp1 and CBF factors in scleroderma fibroblasts.
Cicchillitti L; Jimenez SA; Sala A; Saitta B
Biochem J; 2004 Mar; 378(Pt 2):609-16. PubMed ID: 14613485
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines.
RaschellĂ G; Negroni A; Skorski T; Pucci S; Nieborowska-Skorska M; Romeo A; Calabretta B
Cancer Res; 1992 Aug; 52(15):4221-6. PubMed ID: 1638535
[TBL] [Abstract][Full Text] [Related]
11. Chronic exposure of interleukin-13 suppress the induction of matrix metalloproteinase-1 by tumour necrosis factor α in normal and scleroderma dermal fibroblasts through protein kinase B/Akt.
Brown Lobbins ML; Shivakumar BR; Postlethwaite AE; Hasty KA
Clin Exp Immunol; 2018 Jan; 191(1):84-95. PubMed ID: 28884475
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
[TBL] [Abstract][Full Text] [Related]
13. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro.
Simons M; Rosenberg RD
Circ Res; 1992 Apr; 70(4):835-43. PubMed ID: 1551207
[TBL] [Abstract][Full Text] [Related]
14. Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury.
Villa AE; Guzman LA; Poptic EJ; Labhasetwar V; D'Souza S; Farrell CL; Plow EF; Levy RJ; DiCorleto PE; Topol EJ
Circ Res; 1995 Apr; 76(4):505-13. PubMed ID: 7895327
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.
Citro G; Szczylik C; Ginobbi P; Zupi G; Calabretta B
Br J Cancer; 1994 Mar; 69(3):463-7. PubMed ID: 8123474
[TBL] [Abstract][Full Text] [Related]
16. Predictors of the scleroderma phenotype in fibroblasts from systemic sclerosis patients.
Qi Q; Guo Q; Tan G; Mao Y; Tang H; Zhou C; Zeng F
J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):160-8. PubMed ID: 19054252
[TBL] [Abstract][Full Text] [Related]
17. Effects of calcitriol on fibroblasts derived from skin of scleroderma patients.
Boelsma E; Pavel S; Ponec M
Dermatology; 1995; 191(3):226-33. PubMed ID: 8534941
[TBL] [Abstract][Full Text] [Related]
18. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
19. Role of the c-myc proto-oncogene in the proliferation of hereditary gingival fibromatosis fibroblasts.
Tipton DA; Woodard ES; Baber MA; Dabbous MKh
J Periodontol; 2004 Mar; 75(3):360-9. PubMed ID: 15088873
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of smooth muscle cell proliferation and migration in vitro by antisense oligonucleotide to c-myb.
Pitsch RJ; Goodman GR; Minion DJ; Madura JA; Fox PL; Graham LM
J Vasc Surg; 1996 May; 23(5):783-91. PubMed ID: 8667499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
